Epithelial-mesenchymal transition (EMT) promotes invasion and metastasis of pancreatic ductal adenocarcinoma (PDAC).
Epithelial-mesenchymal transition (EMT) plays a major role not only in embryonic development but also in tumor progression. 1 Tumor cells can acquire a mesenchymal phenotype by triggering the intrinsic cellular program of EMT to promote cell invasiveness, thereby facilitating metastasis. 2 The activation of EMT contributes to highly invasive and metastatic properties of pancreatic ductal adenocarcinoma (PDAC). [3] [4] [5] Previous studies have shown that EMT-like histological findings, such as budding and solitary cell infiltration, a decreased level of E-cadherin, and increased levels of vimentin and SMAD3, in PDAC tissue were associated with poor clinical outcomes. [6] [7] [8] [9] [10] [11] [12] Moreover, a growing body of evidence underscores the importance of tumor-stroma interaction in the regulation of EMT in the tumor microenvironment of PDAC. [13] [14] [15] Mesenchymal-epithelial transition (MET) is the reverse phenomenon of EMT and is postulated to be essential for establishing metastatic colonies in distant organs. 16 However, the underlying mechanism of MET during the progression of PDAC is largely unknown. The reason for this gap in our knowledge is mainly the absence of rigorous in vitro models of MET. Perineural invasion is a unique invasive mode and causes intractable pain in patients with PDAC. 17 Perineural space is thought to provide cancer cells a pro-survival and anti-apoptotic environment that allows an extensive tumor spread beyond the primary site along with the peripheral nerves. 18 Frequent perineural invasion in PDAC tissues is associated with dismal prognosis. 19, 20 In our previous study on in vivo perineural invasion using a mouse model, PDAC cells demonstrated the morphological features of focal differentiation at perineural invasion sites. 21 At these sites, tumor cells formed a better-defined gland with obvious polarity compared to PDAC cells infiltrating the fibrous stroma. Focal differentiation at perineural invasion sites is a common morphological finding in clinical samples of PDAC, but the significance of this unique histological finding remains elusive.
In the current study, we examined the prevalence of focal differentiation at perineural invasion sites within samples from 168 surgically resected PDACs. We also related the histological finding to MET, using the surrogate EMT-related markers E-cadherin, SMAD3, and vimentin. Furthermore, utilizing a noncontact co-culturing system, we tested our hypothesis that tumor cell interaction with Schwann cells might be important in inducing MET-like change in carcinoma cells involved in perineural invasion. This study should provide novel insights into the potential role of MET in promoting perineural invasion in the pancreatic cancer microenvironment.
MATERIALS AND METHODS

Patients and tissue samples
Pancreatic cancer specimens were obtained from patients who underwent pancreatectomy at Keio University Hospital between 1991 and 2014 (n ¼ 201). No patients received chemotherapy or radiation therapy before the initial surgery. Resected specimens were fixed in 10% formalin and were cut stepwise at 4 to 6 mm intervals. All specimens containing pancreatic tissue were embedded in paraffin and were evaluated microscopically. Tumor classification and histologic examinations, including tumor location, tumor size, the degrees of lymphatic invasion, venous invasion, or neural invasion, the presence of lymph node metastasis, margin status, and tumor grade, were reviewed and recorded by two study pathologists (Y.M., and M.S.) according to the World Health Organization classification 22 or the Classification of Pancreatic Carcinoma of the Japan Pancreas Society. 23 We excluded special tumor types such as adenosquamous carcinoma, mucinous adenocarcinoma, undifferentiated carcinoma, acinar cell carcinoma, and neuroendocrine carcinoma, so that only conventional PDAC cases were included in the current study. We further excluded 12 cases in which no perineural invasion was detected. As a result, we analyzed a total of 168 PDAC cases with detectable perineural invasion. The median patient age was 68 years (range, 29-87 years); the male to female ratio was 105:63. Tumor stage was evaluated by the tumor-node-metastasis (TNM) staging system approved by the Union for International Cancer Control (UICC). 24 Ten of the 168 patients were excluded from survival analyses because five died before hospital discharge within 30 days from surgery, two patients were lost to follow-up, and three died of other cause such as abdominal aortic aneurysm. 
Histological assessment of focal differentiation
We defined "focal differentiation" as a histological feature of carcinoma cells at perineural space showing better-defined glandular formation with epithelial polarity than that in nearby tumor cells in stroma outside the peripheral nerves ( Fig. 1 Slides were incubated with primary antibodies for 20 min, followed by polymer for 8 min, postpolymer for 8 min, hydrogen peroxide for 5 min, diaminobenzidine tetrahydrochloride for 10 min, and a hematoxylin counterstain for 5 min. SMAD3 immunostaining was performed according to the method previously described 7 using rabbit monoclonal anti-SMAD3 antibody (1:200; C67H9; Cell Signaling Technology, Danvers, MA, USA).
Immunohistochemical evaluation
Immnohistochemical expressions of E-cadherin, SMAD3, and MIB-1 in carcinoma cells at perineural invasion sites and those in stroma nearby within selected slides were evaluated by the two study pathologists (Y.F-N. and Y.M.). If a case showed more distinct E-cadherin membrane localization in tumor cells at perineural space compared to those in stroma, it was defined as "increased" for E-cadherin expression. If there was no significant increase in E-cadherin membrane expression levels between cells at perineural space and those in stroma, it was defined as "not increased". For SMAD3 immunohistochemistry, if a case showed less SMAD3 nuclear accumulation in tumor cells at perineural space compared to those in stroma, it was defined as "decreased". If there was no substantial decrease in nuclear SMAD3 expression levels between cells at perineural space and those in stroma, it was defined as "not decreased". All of the aforementioned histological evaluations on focal differentiation and immunohistochemical analysis were validated through discussion by the two pathologists using multihead microscopy unaware of other data.
Cell culture
Four human PDAC cell lines (Capan-2, Capan-1, PANC-1, and AsPC-1) and murine Schwann cell line SW10 were obtained from the American Type Culture Collection (Manassas, VA, USA). All cell lines were cultured in RPMI 1640 (Sigma-Aldrich) containing 10% heat-inactivated fetal bovine serum (FBS). Immunostaining of E-cadherin, SMAD3, vimentin, and PARD3 was then performed.
Co
RNA preparation and real-time quantitative RT-PCR
After co-culture, total RNA was isolated using RNeasy Kit (Qiagen, Hilden, Germany) and cDNA was synthesized using the PrimeScript RT reagent Kit (Takara Bio) according to the manufacturer's instructions. Real-time quantitative RT-PCR analysis was carried out at least three times, as previously reported. 7 The primer sets were: E-cadherin 
Statistical analysis
Statistical analyses were performed using the Statistical Package for the Social Sciences (SPSS; IBM, Chicago, IL, USA), version 24.0. To assess the association between the presence of focal differentiation with various clinicopathological data including E-cadherin and SMAD3 expressions, the chi-square test was performed. Student's t-test was used to analyze the statistical differences in MIB-1 index of cancer cells at perineural invasion sites and those in stroma. Survival curves were calculated from the date of surgery using the Kaplan-Meier method and were compared using the log-rank test. For all in vitro experiments, statistical analyses were conducted using the Student's ttest. All P values were two-sided, and P < 0.05 were considered statistically significant in all analyses.
RESULTS
Focal differentiation at neural invasion sites in PDAC tissue
We determined the presence or absence of focal differentiation at perineural invasion sites in tumor tissues with detectable perineural invasion resected from 168 PDAC patients (Fig. 1) . We observed focal differentiation in 124 of 168 (74%) tumors. Immunohistochemical analysis of EMTrelated markers revealed a more distinct membrane distribution of E-cadherin, decreased nuclear localization of SMAD3, and decreased expression levels of vimentin in carcinoma cells at perineural invasion sites with focal differentiation compared with invading carcinoma cells in nearby stroma (Fig. 2) . Focal differentiation was significantly associated with increased membrane expression of Ecadherin (P < 0.001) and reduced nuclear accumulation of SMAD3 (P < 0.001; Table 1 ). In addition, we selected 20 pancreatic ductal adenocarcinomas with (N ¼ 10) or without (N ¼ 10) focal differentiation to compare the MIB-1 labeling index of tumor cells inside and outside nerve structures. In the 10 cases with focal differentiation at perineural invasion sites, there was a trend towards higher MIB-1 index associated with cancer cells in perineural spaces (average MIB-1 index, 16%) compared to those in stroma (average MIB-1 index, 11%) though not statistically significant (P ¼ 0.056, Fig. S1 ). However, in the 10 cases without focal differentiation, there appeared to be no striking difference regarding MIB-1 index between carcinoma cells inside and outside of nerve structures (average MIB-1 index, 17% vs 15%, respectively; P ¼ 0.749). Clinicopathological characteristics according to the presence or absence of focal differentiation at perineural invasion sites are shown in Table S1 . The presence of focal differentiation was significantly associated with higher degrees of venous invasion (P ¼ 0.046) and neural invasion (P < 0.001), positive margin status (P ¼ 0.008), and lower tumor grade (P ¼ 0.001). In our exploratory analyses, we further conducted survival analyses (Fig. 3) to assess the prognostic association of focal differentiation in pancreatic ductal adenocarcinoma. Although there was a trend towards the presence of focal differentiation at perineural invasion sites associated with shorter overall survival [5-year survival rate; 28.4% (Present, N ¼ 117) vs 54.6% (Absent, N ¼ 41)], we did not observe any statistical difference by the log-rank test (p ¼ 0.366, Fig. 3a) . Considering the strong association between focal differentiation and tumor grade, we have hypothesized that the prognostic effect of focal differentiation might be confounded by that of tumor grade. Therefore, to control its confounding effect, we assessed the prognostic association of focal differentiation among patients with low tumor grade (grade 1/2), and found that grade 1/2 tumors with focal differentiation showed poor overall survival compared to those without focal differentiation (P ¼ 0.019 by the log-rank test, Fig. 3b ). Of note, grade 3 tumors showed a worse overall survival than the other two groups in Fig. 3b (P < 0.001 for the three groups).
Because marked focal differentiation was mostly found in tumor cells directly contacting the endoneurium surrounding the myelin sheath within pancreatic nerves, we hypothesized that tumor cell interaction with Schwann cells, the main component of nerve tissue, may play an important role in causing the MET-like change in PDAC cells invading the perineural space.
Co-culture with Schwann cells induced MET-like change in PDAC cells
To determine whether MET-like tumor change is induced by interaction with Schwann cells, we conducted in vitro coculture of PDAC cells with Schwann cells. In the noncontact co-culturing system used in the experiments, PDAC cells formed sheet-like layered structures (Fig. 4a) , whereas monocultured tumor cells formed piled-up clusters or Figure 2 Localization of E-cadherin, SMAD3, and vimentin in tumor cells with focal differentiation. In low magnification images (left column) of serial sections from a case of pancreatic ductal adenocarcinoma, focal differentiation is observed in perineural space (N, nerve). At high magnification, cancer cells at the perineural space (arrows; right column) exhibit clearer linear membrane distribution of E-cadherin along with cell-cell contact compared with those in stroma nearby (black arrowheads; middle column). Cancer cells invading stroma show strong nuclear accumulation of SMAD3 (black arrowheads; the middle column), whereas cancer cells at the perineural space exhibit lower levels of nuclear SMAD3 expression (arrows; the right column). Several cancer cells invading stroma express vimentin (a white arrowhead; the middle column) although no cancer cell at the perineural space show its expression (arrows; the right column). The peripheral nerve is labeled by anti S-100 antibody. Bar ¼ 50 mm.
exhibited a nonadhesive phenotype. Immunocytochemical analysis demonstrated stronger E-cadherin expression along lateral cell membranes in co-cultured PDAC cells than that in monocultured cells. Moreover, nuclear expression levels of SMAD3 were lower in co-cultured PDAC cells compared to those in monocultured cells. Decreased vimentin expression was evident in co-cultured PANC-1 and AsPC-1 cells, whereas vimentin was not detected in Capan-2 or Capan-1 cells in either co-culture or monoculture at the protein level. For further investigation, PARD3 immunostaining was performed to examine cell polarity, however, we did not ascertain tight junction formation in PDAC cell lines in the current assays (Fig. S2) . Expressions of E-cadherin, SMAD3, and vimentin at the mRNA level were then analyzed using real-time quantitative RT-PCR ( 
DISCUSSION
Focal differentiation was a common histological finding at perineural invasion sites in the current study, which is consistent with findings in in vivo mouse models 21 and in clinical samples. Immunohistochemical analyses indicated that focal differentiation was closely associated with changes in levels of EMT-related markers, including E-cadherin and SMAD3, which suggested that focal differentiation in PDAC tissues is associated with MET. Moreover, MET-like morphological and molecular features were observed in PDAC cell lines co-cultured with Schwann cells. Tumor cells can alter their cellular phenotype partially or completely between mesenchymal and epithelial states by triggering the intrinsic developmental EMT/MET program, thereby promoting invasion and metastasis in a number of cancer types, including PDAC. 1, 4, [25] [26] [27] [28] [29] Previous studies have underscored the importance of tumor-stroma interaction in the regulation of EMT/MET in the tumor microenvironment. [13] [14] [15] 30 A previous study suggested that adhesive interaction between tumor cells and Schwann cells contributes to pancreatic perineural invasion. 31 Therefore, our findings may have implications for the functional role of Intratumoral heterogeneity is a prominent histological characteristic of PDAC. [32] [33] [34] [35] In fact, PDAC shows striking morphological heterogeneity: a tumor often has both welldifferentiated and poorly-differentiated elements coexisting in one lesion. Our previous study showed that solitary cell infiltration is common in PDAC, and such cells possess an EMT-related phenotype. 6 The current study revealed that MET-like plastic change in the perineural space is a common feature of PDAC. A growing body of evidence attests to the significance of genetic and epigenetic subclones in patients with PDAC. 36, 37 The intratumoral heterogeneity of PDAC is likely regulated by reversible and irreversible mechanisms, including genetic variations and EMT/MET. In a previous study, we found that the nuclear accumulation of SMAD3 was correlated with EMT hallmarks in PDAC tissues, and knockdown of SMAD3 resulted in reduced motility of PDAC cells. 7 The current analysis showed that the nuclear accumulation of SMAD3 was not prevalent in tumor cells that formed well-defined glands with high levels of E-cadherin expression. This finding suggests that SMAD3-dependent EMT induction is abolished in the process of perineural invasion. MET-like morphological and molecular changes likely occur just after invasion into the nerve, because the focal differentiation of PDAC cells is frequently observed in the perineural space. 21 The mesenchymal state resulting from EMT in cancer cells is transient and cannot be maintained without EMT inducers. Therefore, the microenvironment of the pancreatic nerve may prevent tumor cells from maintaining the mesenchymal state. This would lead to restoration of the epithelial phenotype, which is necessary for establishing well-differentiated colonies in the nerve. Our previous study has demonstrated that SMAD3 overexpression and its nuclear translocation in pancreatic ductal adenocarcinoma contribute to the induction of EMT regardless of the tumor status of SMAD4, which has been essential for the activation of TGF-beta signaling pathway. 7 Therefore, the nuclear accumulation of SMAD3 was used as a biomarker of EMT activation in the current analyses. Previous studies have underscored the importance of variations in SMAD3 phosphorylation-isoforms in triggering differing oncogenic pathways. 38 Future studies on various types of SMAD3 phosphorylation-isoforms may clarify the potential role of SMAD3 in EMT/MET pathways of pancreatic cancer cells. Capan-2, Capan-1, and PANC-1 cells co-cultured with Schwann cells generally showed reduced cell motility in combination with acquisition of an epithelial phenotype, whereas AsPC-1 cells had increased cell motility, suggesting that the role of humoral factors in the co-culture medium on migratory activity of tumor cells may differ by tumor cell types.
There are several limitations of the current study, including the use of mouse Schwann cell lines for in vitro analysis. This was necessary, however, because there is no commercially available human Schwann cell line that can be cultured in the same medium as that used for PDAC cell lines. Nonetheless, our hypothesis that tumor cell interaction with Schwann cells may be important in inducing MET-like change was formulated based on observations in our previously established mouse model for perineural invasion. 21, 39 In addition, we characterized MET-like morphology at perineural invasion sites using surrogate EMT markers. Another limitation is that there is the potential for misclassification of focal differentiation in resected PDAC tissues. The assessment of focal differentiation was performed by two board-certified pancreatic pathologists (Y.F-N. and Y.M.) who were blinded to immunohistochemical data. Furthermore, we were able to observe strong associations of focal differentiation with E-cadherin and SMAD3 expressions (P < 0.001), which supports the reliability of our histopathologic assessment.
In conclusion, this is the first report showing that MET in PDAC cells is induced at perineural invasion sites by interaction with Schwann cells. We believe that understanding this mechanism will create the possibility of new individualized therapy targeting EMT/MET for patients with PDAC.
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